ArticleRadiation oncology (London, England)2012

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy.

Ingeborg Fraunholz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.